Phibro Animal Health Corp
PAHC41.880USD
-1.350-3.12%
Close 11/28, 13:00（ET）Quotes delayed by 15 min
1.70BMarket Cap
25.00P/E TTM
More Details of Phibro Animal Health Corp Company
Phibro Animal Health Corporation is a global diversified animal health and mineral nutrition company. It develops, manufactures and markets a range of products for food and companion animals, including poultry, swine, beef and dairy cattle, aquaculture and dogs. It markets approximately 750 product lines in over 80 countries to approximately 4,200 customers. It has three segments: Animal Health, Mineral Nutrition and Performance Products. Its Animal Health segment develops, manufactures and markets about 280 product lines, including antibacterials, anticoccidials and related products; nutritional specialty products; and vaccines. The Mineral Nutrition segment is comprised of formulations and concentrations of trace minerals such as zinc, manganese, copper, iron and other compounds, with a focus on customers in North America. The Performance Products segment manufactures and markets specialty ingredients for use in the personal care, industrial chemical and chemical catalyst industries.
Phibro Animal Health Corp Info
Ticker SymbolPAHC
Company namePhibro Animal Health Corp
IPO dateApr 11, 2014
CEOMr. Jack C. Bendheim
Number of employees1940
Security typeOrdinary Share
Fiscal year-endApr 11
AddressGlenpointe Centre East, 3Rd Floor
CityTEANECK
Stock exchangeNASDAQ Global Market Consolidated
CountryUnited States of America
Postal code07666
Phone12013297300
Websitehttps://www.pahc.com/
Ticker SymbolPAHC
IPO dateApr 11, 2014
CEOMr. Jack C. Bendheim
Company Executives of Phibro Animal Health Corp
Name
Name/Position
Position
Shareholding
Change
Mr. E. Thomas (Tom) Corcoran
Mr. E. Thomas (Tom) Corcoran
Independent Director
Independent Director
31.24K
+4.14%
Mr. Glenn C. David
Mr. Glenn C. David
Chief Financial Officer
Chief Financial Officer
30.00K
-13.90%
Mr. Larry Lee Miller
Mr. Larry Lee Miller
Chief Operating Officer
Chief Operating Officer
30.00K
-14.73%
Mr. Daniel M. Bendheim
Mr. Daniel M. Bendheim
Executive Vice President - Corporate Strategy, Director
Executive Vice President - Corporate Strategy, Director
3.96K
--
Mr. Jonathan Bendheim
Mr. Jonathan Bendheim
Senior Vice President - Global Technology and Talent, Director
Senior Vice President - Global Technology and Talent, Director
3.27K
--
Mr. Anthony Andolino
Mr. Anthony Andolino
Vice President - Finance, Treasurer
Vice President - Finance, Treasurer
1.79K
--
Ms. Carol A. Wrenn
Ms. Carol A. Wrenn
Independent Director
Independent Director
1.00K
--
Mr. Sam Gejdenson
Mr. Sam Gejdenson
Independent Director
Independent Director
--
--
Ms. Judith A. Weinstein
Ms. Judith A. Weinstein
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
--
--
Ms. Joyce J. Lee
Ms. Joyce J. Lee
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. E. Thomas (Tom) Corcoran
Mr. E. Thomas (Tom) Corcoran
Independent Director
Independent Director
31.24K
+4.14%
Mr. Glenn C. David
Mr. Glenn C. David
Chief Financial Officer
Chief Financial Officer
30.00K
-13.90%
Mr. Larry Lee Miller
Mr. Larry Lee Miller
Chief Operating Officer
Chief Operating Officer
30.00K
-14.73%
Mr. Daniel M. Bendheim
Mr. Daniel M. Bendheim
Executive Vice President - Corporate Strategy, Director
Executive Vice President - Corporate Strategy, Director
3.96K
--
Mr. Jonathan Bendheim
Mr. Jonathan Bendheim
Senior Vice President - Global Technology and Talent, Director
Senior Vice President - Global Technology and Talent, Director
3.27K
--
Mr. Anthony Andolino
Mr. Anthony Andolino
Vice President - Finance, Treasurer
Vice President - Finance, Treasurer
1.79K
--
Revenue Breakdown
Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
MFAs and Other
646.35M
49.86%
Nutritional specialties
179.29M
13.83%
Vaccines
137.15M
10.58%
By RegionUSD
Name
Revenue
Proportion
United States
739.92M
57.08%
Latin America and Canada
298.65M
23.04%
Europe & Middle East & Africa
160.23M
12.36%
Asia Pacific
97.42M
7.52%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
MFAs and Other
646.35M
49.86%
Nutritional specialties
179.29M
13.83%
Vaccines
137.15M
10.58%
Shareholding Stats
Updated: Tue, Nov 18
Updated: Tue, Nov 18
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
14.28%
The Vanguard Group, Inc.
7.44%
State Street Investment Management (US)
4.37%
Acadian Asset Management LLC
3.84%
Renaissance Technologies LLC
2.72%
Other
67.35%
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
14.28%
The Vanguard Group, Inc.
7.44%
State Street Investment Management (US)
4.37%
Acadian Asset Management LLC
3.84%
Renaissance Technologies LLC
2.72%
Other
67.35%
Shareholder Types
Shareholders
Proportion
Investment Advisor
55.42%
Investment Advisor/Hedge Fund
29.53%
Hedge Fund
8.81%
Research Firm
3.30%
Pension Fund
1.72%
Individual Investor
0.52%
Bank and Trust
0.46%
Corporation
0.29%
Sovereign Wealth Fund
0.05%
Institutional Shareholding
Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
390
21.83M
106.75%
-2.29M
2025Q2
377
20.85M
102.34%
-3.11M
2025Q1
383
21.67M
106.42%
-2.98M
2024Q4
360
21.95M
107.94%
-1.91M
2024Q3
348
21.46M
105.50%
-2.61M
2024Q2
357
21.32M
104.83%
-3.05M
2024Q1
350
21.49M
105.66%
-2.40M
2023Q4
349
21.13M
103.91%
-1.66M
2023Q3
339
20.38M
100.19%
-2.22M
2023Q2
341
20.61M
101.32%
-2.12M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
BlackRock Institutional Trust Company, N.A.
2.94M
14.45%
-161.95K
-5.22%
Jun 30, 2025
The Vanguard Group, Inc.
1.54M
7.58%
+26.73K
+1.76%
Jun 30, 2025
State Street Investment Management (US)
909.33K
4.46%
-10.87K
-1.18%
Jun 30, 2025
Acadian Asset Management LLC
724.44K
3.56%
-58.50K
-7.47%
Jun 30, 2025
Renaissance Technologies LLC
610.80K
3%
-94.50K
-13.40%
Jun 30, 2025
Geode Capital Management, L.L.C.
554.93K
2.72%
+7.84K
+1.43%
Jun 30, 2025
Dimensional Fund Advisors, L.P.
557.24K
2.74%
-86.67K
-13.46%
Jun 30, 2025
Nuveen LLC
458.57K
2.25%
-23.24K
-4.82%
Jun 30, 2025
Castleknight Management LP
531.35K
2.61%
+113.60K
+27.19%
Jun 30, 2025
View more
Related ETFs
Updated: Thu, Nov 6
Updated: Thu, Nov 6
Name
Proportion
AAM Sawgrass US Small Cap Quality Growth ETF
2.43%
SPDR S&P Pharmaceuticals ETF
1.06%
Brandes US Small-Mid Cap Value ETF
1.04%
Invesco S&P SmallCap 600 Pure Growth ETF
1%
Inspire Fidelis Multi Factor ETF
1%
Lattice Hartford Multifactor Small Cap ETF
0.82%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
0.79%
Invesco Dorsey Wright Healthcare Momentum ETF
0.79%
Innovator IBD 50 Fund ETF
0.71%
Invesco NASDAQ Future Gen 200 ETF
0.53%
View more
AAM Sawgrass US Small Cap Quality Growth ETF
Proportion2.43%
SPDR S&P Pharmaceuticals ETF
Proportion1.06%
Brandes US Small-Mid Cap Value ETF
Proportion1.04%
Invesco S&P SmallCap 600 Pure Growth ETF
Proportion1%
Inspire Fidelis Multi Factor ETF
Proportion1%
Lattice Hartford Multifactor Small Cap ETF
Proportion0.82%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
Proportion0.79%
Invesco Dorsey Wright Healthcare Momentum ETF
Proportion0.79%
Innovator IBD 50 Fund ETF
Proportion0.71%
Invesco NASDAQ Future Gen 200 ETF
Proportion0.53%
Dividend
A total of
97.20M
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
Feb 04, 2025
PAHC.NB Interim Cash Dividend of gross USD 0.12 paid on Mar 26, 2025 going ex on Mar 05, 2025
Mar 05, 2025
Mar 26, 2025
Mar 05, 2025
Nov 05, 2024
PAHC.NB Final Cash Dividend of gross USD 0.12 paid on Dec 18, 2024 going ex on Nov 27, 2024
Nov 27, 2024
Dec 18, 2024
Nov 27, 2024
Jul 30, 2024
PAHC.NB Interim Cash Dividend of gross USD 0.12 paid on Sep 25, 2024 going ex on Sep 04, 2024
Sep 04, 2024
Sep 25, 2024
Sep 04, 2024
May 07, 2024
PAHC.NB Interim Cash Dividend of gross USD 0.12 paid on Jun 26, 2024 going ex on Jun 05, 2024
Jun 05, 2024
Jun 26, 2024
Jun 05, 2024
Feb 06, 2024
PAHC.NB Interim Cash Dividend of gross USD 0.12 paid on Mar 27, 2024 going ex on Mar 05, 2024
Mar 06, 2024
Mar 27, 2024
Mar 05, 2024
Nov 06, 2023
PAHC.NB Final Cash Dividend of gross USD 0.12 paid on Dec 20, 2023 going ex on Nov 28, 2023
Nov 29, 2023
Dec 20, 2023
Nov 28, 2023
Jul 25, 2023
PAHC.NB Interim Cash Dividend of gross USD 0.12 paid on Sep 27, 2023 going ex on Sep 05, 2023
Sep 06, 2023
Sep 27, 2023
Sep 05, 2023
May 01, 2023
PAHC.NB Interim Cash Dividend of gross USD 0.12 paid on Jun 28, 2023 going ex on Jun 06, 2023
Jun 07, 2023
Jun 28, 2023
Jun 06, 2023
Feb 06, 2023
PAHC.NB Interim Cash Dividend of gross USD 0.12 paid on Mar 22, 2023 going ex on Feb 28, 2023
Mar 01, 2023
Mar 22, 2023
Feb 28, 2023
Nov 07, 2022
PAHC.NB Final Cash Dividend of gross USD 0.12 paid on Dec 21, 2022 going ex on Nov 29, 2022
Nov 30, 2022
Dec 21, 2022
Nov 29, 2022
View more
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of Phibro Animal Health Corp?
The top five shareholders of Phibro Animal Health Corp are:
BlackRock Institutional Trust Company, N.A. holds 2.94M shares, accounting for 14.45% of the total shares.
The Vanguard Group, Inc. holds 1.54M shares, accounting for 7.58% of the total shares.
State Street Investment Management (US) holds 909.33K shares, accounting for 4.46% of the total shares.
Acadian Asset Management LLC holds 724.44K shares, accounting for 3.56% of the total shares.
Renaissance Technologies LLC holds 610.80K shares, accounting for 3.00% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 2.94M shares, accounting for 14.45% of the total shares.
The Vanguard Group, Inc. holds 1.54M shares, accounting for 7.58% of the total shares.
State Street Investment Management (US) holds 909.33K shares, accounting for 4.46% of the total shares.
Acadian Asset Management LLC holds 724.44K shares, accounting for 3.56% of the total shares.
Renaissance Technologies LLC holds 610.80K shares, accounting for 3.00% of the total shares.
What are the top three shareholder types of Phibro Animal Health Corp?
The top three shareholder types of Phibro Animal Health Corp are:
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
State Street Investment Management (US)
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
State Street Investment Management (US)
How many institutions hold shares of Phibro Animal Health Corp (PAHC)?
As of 2025Q3, 390 institutions hold shares of Phibro Animal Health Corp, with a combined market value of approximately 21.83M, accounting for 106.75% of the total shares. Compared to 2025Q2, institutional shareholding has increased by 4.41%.
What is the biggest source of revenue for Phibro Animal Health Corp?
In FY2025, the MFAs and Other business generated the highest revenue for Phibro Animal Health Corp, amounting to 646.35M and accounting for 49.86% of total revenue.
